#24-419 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Fondia Plc: Share repurchase 5.12.2024
Reading Time: < 1 minute Fondia Plc Company release 5.12.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 5.12.2024 Fondia Plc First North Finland Date 5.12.2024 Exchange transactions Buy Share class FONDIA Amount, shares 977 Average price/share, EUR 4,913060
Pricer has successfully issued bonds of SEK 300 million and exercises its right to voluntary early redemption of its existing bonds
Reading Time: 3 minutes NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE
WPTG acquires Nordic technology consultancy Nuport and resolves on a directed share issue
Reading Time: 3 minutes White Pearl Technology Group AB (publ) (“WPTG”) has today entered into an agreement regarding the acquisition of, and taking possession of, all shares (the “Shares”) in Nuport Sverige AB (“Nuport”). The seller of Nuport Sverige AB will receive newly issued shares in
Observe Medical ASA: Final result of the subsequent offering and allocation of shares; Updated amendments of loans from Navamedic ASA to be implemented including partial conversion to shares
Reading Time: 7 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT
Hansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in Anti-Glomerular Basement Membrane Disease
Reading Time: 4 minutes Data from the trial is expected to be shared in 2025 Lund, Sweden, 5 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) today announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial
Belden Debuts New Corporate Brand Platform
Reading Time: 2 minutes Belden Inc. St. Louis, United States: Belden Inc. (NYSE: BDC), today revealed a new corporate brand identity that underscores the company’s transformation to a comprehensive network and data infrastructure solutions provider. These solutions play a pivotal role in addressing automation and
Japan Credit Rating Agency awards SMFG India Credit AA- Rating, 4 Notches Above India’s Sovereign Rating
Reading Time: 2 minutes SMFG India Credit (SMICC), a wholly-owned subsidiary of Sumitomo Mitsui Financial Group (SMFG), has been awarded an international credit rating of “AA-” with a stable outlook by the Japan Credit Rating Agency (JCR). This exceptional outcome places SMICC four notches above India’s sovereign rating and
HDFC Life’s ‘Life Freedom Index’ (LFI) Shows a Bounce-back in Consumers’ Financial Outlook Across Cohorts, Up 9 Points Post-COVID
Reading Time: 3 minutes HDFC Life, one of India’s leading life insurers, has released the latest edition of Life Freedom Index (LFI). The LFI is a study that was established by HDFC Life in 2011. This index measures the level of ‘financial freedom’ among Indian consumers, and has been
National award for Teesside University building
Reading Time: 3 minutes A state-of-the art Teesside University science facility providing cutting edge training to the next generation of health and medical professionals has received a prestigious national award. The University achieved a memorable hat-trick at the Constructing Excellence National Awards, scooping building project